Telemedicine in heart failure, the pending road

Authors

  • Pablo Roldán Santos Medico Facultad de Medicina de Albacete, España
  • Loreto Tarraga Marcos Enfermera Hospital Clinico de Zaragoza, España
  • Fátima Madrona Marcos Médico Residente del EAP Zona 5 A Albacete, España
  • Ibrahim Sadeh M. Médico Residente del EAP Zona 5 A Albacete, España
  • Carmen Celada Roldan Médico Familia Cartagena. Murcia, España
  • Josefa María Panisello Royo Médico internista, Presidente Fundación Fomento Salud. Barcelona, España
  • Pedro Juan Tárraga López Profesor Medicina de Facultad de Medicina de Albacete, España

DOI:

https://doi.org/10.19230/jonnpr.3201

Keywords:

Telemedicine, Heart failure, Mortality, Readmissions

Abstract

Introduction. Heart Failure is a very prevalent disease in developed countries that generates numerous care processes assuming a significant percentage of health expenditure. There is therefore a need to develop a system that makes it possible to reduce the management of these patients without  deteriorating the assistance provided, with telemedicine being established as a valid alternative.

Objectives. This review aims to compare the efficacy of telemedicine-based interventions against standard care in the management of patients with Heart Failure. To assess this efficacy, the performance of telemedicine will be evaluated by appealing to the rates of income and mortality due to Heart Failure or other causes, to the quality of life of these patients and to the costs saved thanks to their employment.

Results. A review of the main search engines and databases was carried out. Among the publications used, there was a reduction in the income rate per CI that ranged between 12-67.8%, a decrease in the mortality rate that varied between 18-34%, an improvement in the quality of life variable according to the questionnaire and finally, a reduction in healthcare costs of 14-86%.

Conclusions. Telemedicine stands as an effective and valid alternative to the usual care for these patients.  More research is needed in the future to be able to unify the different systems thus giving rise to a  universal tool.

 

Downloads

Download data is not yet available.

References

Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 1 de septiembre de 2001;22(17):1527-60.

Generalidades sobre la insuficiencia cardíaca: MedlinePlus enciclopedia médica [Internet]. [citado 4 de abril de 2019]. Disponible en: https://medlineplus.gov/spanish/ency/article/000158.htm

Segovia Cubero J, Alonso-Pulpón Rivera L, Peraira Moral R, Silva Melchor L. Etiología y evaluación diagnóstica en la insuficiencia cardíaca. Rev Esp Cardiol. 1 de marzo de 2004;57(03):250-9.

Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. septiembre de 2007;93(9):1137-46.

Rodríguez-Artalejo F, Banegas Banegas JR, Guallar-Castillón P. Epidemiología de la insuficiencia cardíaca. Rev Esp Cardiol. 1 de febrero de 2004;57(02):163-70.

Anguita Sánchez M, Crespo Leiro MG, de Teresa Galván E, Jiménez Navarro M, Alonso-Pulpón L, Muñiz García J. Prevalencia de la insuficiencia cardiaca en la población general española mayor de 45 años. Estudio PRICE. Rev Esp Cardiol. 1 de octubre de 2008;61(10):1041-9.

González-Juanatey JR, Alegría Ezquerra E, Bertoméu Martínez V, Conthe Gutiérrez P, Santiago Nocito A de, Zsolt Fradera I. Insuficiencia cardiaca en consultas ambulatorias: comorbilidades y actuaciones diagnóstico- terapéuticas por diferentes especialistas. Estudio EPISERVE. Rev Esp Cardiol. 1 de junio de 2008;61(06):611-9.

Delgado JF, Oliva J, Llano M, Pascual-Figal D, Grillo JJ, Comín-Colet J, et al. Costes sanitarios y no sanitarios de personas que padecen insuficiencia cardiaca crónica sintomática en España. Revista Española de Cardiología. 1 de agosto de 2014;67(8):643-50.

Sayago-Silva I, García-López F, Segovia-Cubero J. Epidemiología de la insuficiencia cardiaca en España en los últimos 20 años. Rev Esp Cardiol. 1 de agosto de 2013;66(08):649-56.

Paré G, Jaana M, Sicotte C. Systematic Review of Home Telemonitoring for Chronic Diseases: The Evidence Base. J Am Med Inform Assoc. 2007;14(3):269-77.

WHO Global Observatory for eHealth. MHealth: new horizons for health through mobile technologies. Geneva: World Health Organization; 2011.

Escobar-Curbelo L, Franco-Moreno AI. Application of Telemedicine for the Control of Patients with Acute and Chronic Heart Diseases. Telemed J E Health. 15 de diciembre de 2018;

Peterson CB, Hamilton C, Hasvold P. From innovation to implementation: eHealth in the WHO European region. Copenhagen, Denmark: WHO Regional Office for Europe; 2016. 98 p.

Hwang R, Mandrusiak A, Morris NR, Peters R, Korczyk D, Russell T. Assessing functional exercise capacity using telehealth: Is it valid and reliable in patients with chronic heart failure? J Telemed Telecare. febrero de 2017;23(2):225-32.

Cleland JGF, Louis AA, Rigby AS, Janssens U, Balk AHMM, TEN-HMS Investigators. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol. 17 de mayo de 2005;45(10):1654- 64.

Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, et al. Telemonitoring in Patients with Heart Failure. N Engl J Med. 9 de diciembre de 2010;363(24):2301-9.

Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. The Lancet. 19 de febrero de 2011;377(9766):658-66.

Domingo M, Lupón J, González B, Crespo E, López R, Ramos A, et al. Noninvasive Remote Telemonitoring for Ambulatory Patients With Heart Failure: Effect on Number of Hospitalizations, Days in Hospital, and Quality of Life. CARME (CAtalan Remote Management Evaluation) Study. Rev Esp Cardiol. 1 de abril de 2011;64(04):277-85.

Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet. 20 de agosto de 2011;378(9792):731-9.

Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, et al. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. European Journal of Heart Failure. diciembre de 2010;12(12):1354-62.

Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JGF. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. Eur J Heart Fail. septiembre de 2011;13(9):1028-40.

Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation. 19 de junio de 2012;125(24):2985-92.

Lemay G, Azad N, Struthers C. Utilization of home telemonitoring in patients 75 years of age and over with complex heart failure. J Telemed Telecare. enero de 2013;19(1):18-22.

Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, et al. Implantbased multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 16 de agosto de 2014;384(9943):583-90.

Comín-Colet J, Enjuanes C, Verdú-Rotellar JM, Linas A, Ruiz-Rodriguez P, González-Robledo G, et al. Impact on clinical events and healthcare costs of adding telemedicine to multidisciplinary disease management programmes for heart failure: Results of a randomized controlled trial. J Telemed Telecare. julio de 2016;22(5):282-95.

Jiménez-Marrero S, Yun S, Cainzos-Achirica M, Enjuanes C, Garay A, Farre N, et al. Impact of telemedicine on the clinical outcomes and healthcare costs of patients with chronic heart failure and mid-range or preserved ejection fraction managed in a multidisciplinary chronic heart failure programme: A sub-analysis of the iCOR randomized trial. J Telemed Telecare. 7 de septiembre de 2018;1357633X18796439.

Klersy C, Boriani G, De Silvestri A, Mairesse GH, Braunschweig F, Scotti V, et al. Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta-analysis of randomized controlled trials in patients with heart failure. Eur J Heart Fail. febrero de 2016;18(2):195-204.

Knox L, Rahman RJ, Beedie C. Quality of life in patients receiving telemedicine enhanced chronic heart failure disease management: A meta-analysis. J Telemed Telecare. agosto de 2017;23(7):639-49.

Lin M-H, Yuan W-L, Huang T-C, Zhang H-F, Mai J-T, Wang J-F. Clinical effectiveness of telemedicine for chronic heart failure: a systematic review and meta-analysis. J Investig Med. 2017;65(5):899-911.

Published

2019-10-11